CRRTNet Registry- A Prospective Observational Registry

Continuous Renal Replacement Therapy Clinical Trial

— CRRT  

Official title:

CRRTNet Outcome Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02034448
• Other study ID #: CRRTNet
• Status: Recruiting
• Phase: N/A
• First received: January 10, 2014
• Last updated: January 12, 2015
• Start date: November 2013
• Est. completion date: December 2018

Study information

• Verified date: January 2015
• Source: AKI Critical Care Research Foundation
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

An observational registry to monitor the outcome of CRRT in adults with acute kidney injury.

Description:

Continuous Renal Replacement Therapy (CRRT) is a form of dialysis provided to critically ill patients with acute renal failure, now known as acute kidney injury (AKI). While we have extensive experience with this therapy in critically ill patients, there is no consensus on when to start CRRT or a clinical standard as to the best possible way to deliver the therapy. Previous studies have examined one aspect of CRRT in detail (for instance the dose of delivered therapy, or anticoagulation strategies) or have been small single center studies, or large multinational studies examining very basic practice patterns. This is a prospective observational cohort study. All patients who receive CRRT as part of their standard of local care will be eligible for the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria: Patients initiating CRRT c. Age > 18 years of age and <89 year of age -

Exclusion Criteria: ? 18 years of age and > 89 year of age

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Continuous Renal Replacement Therapy

Intervention

Procedure:
• Continuous Renal Replacement Therapy

Locations

Country	Name	City	State
United States	Mike Heung	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
AKI Critical Care Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality		30 days	No
Secondary	Length of Stay		6 months	No